Many biochemical studies on skeletal muscle have been reported in experimental muscular dystrophy of animals. The effect of vitamin E deficiency on muscle metabolism has been most intensively studied. The disease of animals which most closely resembles human muscular dystrophy by genetic and histologic criteria is the hereditary primary myopathy of the mouse (1) .
This mutant muscle disease of the mouse provides a useful tool for research. However, the metabolic and etiologic correspondence with human muscular dystrophy is not yet established. It would appear, therefore, that it might be worthwhile to study muscular dystrophy in man by chemical analysis of muscle obtained at biopsy from patients with this disease. This report describes some biochemical studies on the skeletal muscles of patients with progressive muscular dystrophy. This disease is of particular interest because it is the most frequently occurring primary myopathy and may be regarded as the prototype of primary degenerative muscle disease. Skeletal muscle secondarily atrophic due to neurogenic disease of the lower motor neuron has been studied to determine whether biochemical changes in dystrophic muscle are due to nonspecific effects of muscle wasting. Diagnosis in all patients was based on combined clinical and histologic findings. Clinically, all the dystrophy patients were ambulatory and in the early stages of the disease by functional classification and extent of muscle involvement. It was hoped that any characteristic biochemical alterations might be better appreciated in the muscles of early disease rather than in the replaced and scarred tissue of advanced disease. In the latter case, similar end stage changes may be seen in any type of chronic myopathy. *This work has been supported by a grant from the Muscular Dystrophy Association of America, Inc.
METHODS
The study was done on skeletal muscle obtained by surgical biopsy. Muscle was excised under general anesthesia in both patients and controls. One type of general anesthesia, cyclopropane, was used in all patients in order to reduce one potential source of experimental variation. Normal control muscle samples were secured from individuals with no clinical evidence of muscle weakness. The muscle was normal by histologic examination. This group was composed of seven females and three males varying in age between 2 and 47, with a median age of 30. A second group of controls had muscle disease secondary to neurogenic causes. Muscular dystrophy patients studied were ambulatory for the purpose of diminishing the factor of nonspecific disuse atrophy.
There is no universal agreement on classification in progressive muscular dystrophy. Indeed the classification of muscular dystrophy has been the source of dispute for many years (2) . The clinical picture, in all 17 of the muscular dystrophy cases in this study, corresponds best with the classification of so-called "childhood type" of dystrophy described by Tyler and Stephens (3) .
On the basis of the experimental biochemical data, the 17 subjects with childhood type muscular dystrophy are divided into two groups. These two groups appeared to have different metabolic patterns on the basis of the biochemical studies of muscle. The separation of the dystrophy cases into two categories has been done for the purpose of better handling of the experimental results. It is not the intention of this paper to offer still another classification of dystrophy. The clinical differences between the two groups of muscular dystrophy patients in this paper were in the age at onset of muscle weakness and the age at time of muscle biopsy. The 17 cases of muscular dystrophy were divided by these age criteria into two arbitrary groups. Those under the age of 20, at time of surgical muscle biopsy, are termed juvenile dystrophy, while those over 20 years of age at this time are called adult dystrophy. These two patient groups are further differentiated by the age when muscle weakness was first noted. The group termed juvenile dystrophy had muscle weakness beginning before the age of six years, while the so-called adult dystrophy patients' symptoms began after the age of six.
Symptoms of muscle weakness in both groups were first noted in activities involving the muscles of the pelvic girdle. No patient had the first symptoms referrable to the muscles of the pectoral girdle. It is recognized that the history of initial muscle involvement may be misleading, but the pattern of muscle weakness in no case indicated a disproportionate early or severe involvement of the pectoral girdle or facial muscles, as is seen in the facioscapulohumeral type of dystrophy. The pattern of muscle involvement, joint contractures and family history were similar in the two groups of muscular dystrophy. Contractures seem to be largely secondary to muscle imbalance and were present in all cases (4) . There is only an occasional patient with a family history of muscle weakness. All cases showed progression of muscle weakness and there was no plateau in any patient as may be seen in polymyositis.
The pattern of individual muscle weakness was determined by manual muscle tests. All biopsied muscles used in this study were values. In order to arrive at a figure that would indicate the relative mass as well as the strength of the muscles, the numerical value was then multiplied by a factor rating ranging from one to four. The tibialis anterior muscle was selected as the muscle representing the standard of one. This factor rating is considered to remain relatively constant even with generalized atrophy. 'The above method was adapted from the work done to standardize muscle testing and evaluate function of the early poliomyelitis patient in relation to gamma globulin and polio vaccine trials (6) . Although a complete and comprehensive muscle evaluation was done by the physical therapist, for the purposes of this study, the quantitative comparison was limited to 22 major muscles of the trunk and extremities which were considered to be a representative sampling of the muscle involvement.
On this basis, a total score of 700 is the maximum that could be achieved by an individual who was rated "normal" for each muscle tested.
Muscle biopsies were taken from the rectus abdominis muscle in all controls and dystrophy patients. In three neurogenic atrophy patients this site was not considered suitable because of clinical considerations. This muscle was selected since it is involved early and uniformly in the course of childhood type muscular dystrophy and is easily obtainable from normal controls at laparotomy (3). All determinations were done in duplicate. Enzyme assays were done in duplicate and at two enzyme concentrations as a check on the linearity of the assay. Muscle specimens were wrapped in parafilm immediately after excision to prevent change in water content and immediately chilled in ice. Preparation of the muscle sample for analysis was begun within 10 minutes after removal of muscle at operation. The muscle was minced into a homogenous mash in the cold room at 40 C. The muscle mash was divided into samples of appropriate size for the determinations and wrapped in parafilm to form an air-tight package. Each sample was rapidly weighed on a Roller-Smith Torsion Balance.
Myosin extraction was begun immediately after weighing. Myosin was extracted according to the Hasselbach and Schneider (7) modification of the classic myosin extraction technique. Extraction was done in the cold (40 C.) using two periods of one hour each. Collagen was determined by the method of Lowry, Gilligan and Katersky (8) . Nitrogen determinations were done by a semimicro-Kjeldahl method. Water content was determined after drying for 48 hours at 1050. Fat analysis was carried out on muscle mash samples by extraction with a 2 to 1 chloroform to methanol (v/v) mixture according to the method of Folch and associates (9, 10) .
In a comparative study of diseased and normal muscle, a parenchymal reference base must be used (11) . The use of an adequate tissue reference base enables the investigator to determine net quantities of tissue constituents without the error introduced by varying quantities of nonfunctional fibrous tissue, extracellular water and fat. The tissue reference base used in this study has been noncollagenous nitrogen (12) .
Muscle was prepared for enzyme assays in a Potter Elvehjem homogenizer at 40 C. The homogenizing fluid was 0.12 M KCL and 0.00016 M KHCO3 at pH 7.0. A 1 to 10 homogenate was prepared. This homogenate was used for the succinic dehydrogenase assay performed by the method of Schneider and Potter (13) . Creatine kinase activity was determined on the supernatant obtained by centrifugation of the original homogenate at 4°at 6,500 X G. The term creatine kinase is used to describe the a modification of the system described by LePage (16 (Table III) .
In view of the importance of ATP in muscle metabolism, adenosine triphosphatase activity was examined even though its role in the complex reactions of intact muscle may be more involved than a direct hydrolytic cleavage of ATP. Adenosine triphosphatase activity was essentially normal in adult dystrophy but showed a reduction in juvenile dystrophy and neurogenic atrophy (Table  III) .
Succinic dehydrogenase (Table III) was measured as a representative enzyme of aerobic respiration. There was no change in enzyme activity in dystrophy. Secondary neurogenic atrophy showed a definite decrement but the small sample makes this result of questionable significance.
The most striking enzymatic alteration was the decrease in overall glycolytic activity in juvenile dystrophy. The reduction to approximately onethird control activity is a relatively greater reduction per unit of parenchymal tissue than that exhibited by the other enzymes studied. This reduction in glycolysis is in contrast to adult dystrophy, where the muscle shows a slight reduction based on wet weight, but does not vary significantly when the activity is based on noncollagenous nitrogen (20) . A second suggestion is that the energy supply to the contractile fibril mechanism is faulty (21). In the latter case, the metabolic error may be attributed to some step or steps in the generation of high energy phosphate bonds which serve as the immediate source of energy for the muscle contraction of the myofibril.
In a consideration of the contractile function of muscle, the principal protein of the myofibril is myosin. It has been suggested that its concentration should bear an important quantitative relationship to the total mass of contractile pa- The experiments indicate that myosin is reduced. However, the average reduction in myosin content is markedly less than that of glycolytic activity and slightly less than the reduction in creatine kinase and ATP-ase activity in the group of patients termed "juvenile dystrophy." Although the decrease in myosin content of dystrophic muscle is only moderate in degree, the possibility of a more significant qualitative alteration cannot be ruled out by these experiments.
In human muscular dystrophy, the only previously reported metabolic alterations in enzyme activity have been decreases in overall glycogenolysis and in some individual enzymes of this system, including phosphorylase, phosphoglucomutase and aldolase (22, 23) . The results reported in this paper confirm the absolute decrease of glycolysis in muscular dystrophy but limit this alteration to cases classified here as juvenile dystrophy. The percentile decrease in muscle glycolytic activity to one-third normal activity is in close agreement with the results of Schapira, Dreyfus, Schapira and Kruh (23) . The reduction in glycolysis is considerably greater than the absolute decrease of myosin content, adenosine triphosphatase, or creatine kinase activity. The severe glycolytic alteration in juvenile dystrophies, with only moderate muscle weakness, points to the possible magnitude of the metabolic derangement of muscle in patients with advanced muscle wasting. The role of lactic acid production in energy generation by muscle in states of relative anoxia is well known. Recent experimental evidence suggests that lactate production may also be significant in the resting state (24) . The role of glycolysis in human skeletal muscle metabolism may be of greater importance than has been believed in the past.
All enzyme systems tested including glycolysis are well preserved in the adult with dystrophy. This is particularly impressive when contrasted with the loss of enzyme activity in the juvenile dystrophic. This may represent merely a quantitative difference in disease severity between the two groups. However, the disproportionate decrease in myosin in the adult dystrophic in the face of well maintained enzymatic activity suggests that there may be a different metabolic defect in the two groups.
Dreyfus, Schapira and Schapira (22) speculate whether the muscle weakness in muscular dystrophy is due to enzymatic defects in glycolysis or whether these alterations in metabolism are the sequelae of a more primary biochemical flaw. This present study confirms the decrease in glycolytic activity, but also indicates that there is a significant reduction in myosin concentration and in nonglycolytic enzyme systems involved in high energy phosphate transfer. This indicates that the metabolic deficit in muscular dystrophy is more widespread than suggested by the work of Dreyfus and associates. The present data suggest that the biochemical alterations in dystrophy are complex and involve both myofibrillar and sarcoplasmic components. The disproportionate reduction in activity of the glycolytic system in human dystrophy suggests that further study of the individual components of this system in human dystrophy might be rewarding.
In general, similar quantitative alterations in enzyme activity are found in neurogenic atrophy and juvenile muscular dystrophy. Therefore, none of the changes are specific for the skeletal muscle weakness in muscular dystrophy. The similarity in metabolic alterations in myogenic and neurogenic muscle disease is susceptible to various alternative theories. A common enzyme or cofactor deficiency may lead to the failure of adequate lactic acid production in both types of disease or a stereotyped deficit may result from fundamentally different metabolic errors.
Another possible explanation is that as a result of disease there is an alteration in muscle membrane permeability. It has been demonstrated that the intracellular enzyme, aldolase, diffuses more rapidly from dystrophic mouse muscle than from normal muscle (25) . The low content of intracellular muscle enzymes in human dystrophy could be explained by this mechanism. A similar nonspecific alteration of muscle membrane permeability could occur in neurogenic muscle atrophy. The normal serum aldolase in neurogenic disease of muscle is, however, somewhat against this theory (26) . A continuing problem in assessing the degree of skeletal muscle involvement in myopathy is the factor of tissue heterogeneity. Histologic preparations suffer from the handicap that individual microscopic sections may show widely disparate pictures. It is often difficult for the pathologist to give more than a semiquantitative evaluation of the extent of muscle disease. Quantitative chemical determination of skeletal muscle constituents, in which both the functional and replacement elements of muscle are measured, may aid in the clinical evaluation of muscle disease. These values, which are based on aliquots taken from several grams of homogenized tissue, are probably more representative of overall mean tissue composition in a given muscle than are the individual histologic sections which represent only a few milligrams of muscle tissue. It has been reported that the fat content of diseased dystrophic muscle may vary by 50 per cent in two different areas (11) . Quantitative fat determinations in the group of patients reported in this paper, who have only moderate muscle involvement, vary within a relatively small range. The past reports of marked differences and overall increase in the fat content of dystrophic muscle may well reflect the long duration of the disease process (17) rather than a fundamental alteration of fat metabolism or accelerated lipid deposition in dystrophic muscle. It would appear that in early muscle disease the extent of fat deposition in muscle tissue has no diagnostic significance and, indeed, shows no significant increase over normal control muscle. It seems unwise, therefore, to interpret fat replacement of muscle as indicating a specific metabolic fat defect in muscular dystrophy.
Conversely, a significant increase in the fibrous tissue content of muscle is an early finding in ju-venile muscular dystrophy. This would seem to be a more dependable indication of early muscle dysfunction in this disease than an increase in muscle fat. SUMMARY 1. The content of myosin, creatine kinase, adenosine triphosphatase, succinic dehydrogenase, overall glycolysis, fat, collagen and water in the skeletal muscle of patients with muscular dystrophy has been determined. This has been compared with skeletal muscle analysis in normal controls and neurogenic atrophy.
2. The collagen content of juvenile dystrophic and neurogenic atrophy muscle was increased. The water content of muscle in these two patient groups was reduced slightly. Muscle fat was not significantly altered in any patient group.
3. In juvenile and adult dystrophy, the myosin content related to noncollagenous nitrogen was reduced.
4. Glycolysis showed the most striking decrease of the parenchymal tissue elements tested. This was reduced to one-third of normal in juvenile dystrophy. Since a similar reduction was found in neurogenic atrophy, this is not the specific metabolic derangement in dystrophy.
5. Adenosine triphosphatase and creatine kinase activity were reduced in both juvenile dystrophy and neurogenic atrophy.
6. The muscle of adult dystrophy showed no enzyme alterations although the myosin content was reduced to a greater extent than in the other two patient groups.
